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Despite the effectiveness of an implantable cardioverter deﬁbrillator (ICD), its implantation and
concomitant therapies, including shocks, can induce psychological distress in patients. Depression has
been observed in approximately 30% of ICD patients, and shocks may contribute to the persistence of
depression. Anxiety is common, with reports of 24–87% of ICD patients experiencing symptoms of
anxiety after implantation, and type D personality and ICD-related concerns may play important roles in
the level of anxiety in ICD patients. However, the association between ICD shocks and anxiety is
controversial. The prevalence of posttraumatic stress disorder (PTSD) in ICD patients is approximately
20%, and type D personality, comorbidities, and frequent shocks may contribute to PTSD. It is also
important to pay attention to the psychological distress in the partners of ICD patients.
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An implantable cardioverter deﬁbrillator (ICD) improves survi-
val in patients at high risk of sudden cardiac death, including those
with left ventricular dysfunction and heart failure [1]. Many
studies indicate that an ICD implantation improves the quality of
life (QOL) for most ICD patients [2,3]. However, the severity of an
underlying disease or comorbidities, poor social support, or ICD-
speciﬁc problems such as younger age at implantation, frequent
shocks, and a poor understanding of the therapy may increaset Rhythm Society. Published by Els
okyo Women’s Medical Uni-
, Japan. Tel.: +81 3 3353 8111;
MD).anxiety and depressive symptoms in ICD patients [3–5]. Despite
the effectiveness of an ICD in the prevention of sudden cardiac
death, the implantation of an ICD and its concomitant therapies,
including both appropriate and inappropriate shocks, can induce
high levels of psychological distress such as depression, anxiety,
anger, or posttraumatic stress symptoms in patients and their
partners (Fig. 1). These psychological issues are major problems for
patients receiving long-term ICD therapy; therefore, cardiologists
and clinical electrophysiologists should screen for psychological
distress and recommend appropriate referrals for these patients.
2. Depression
Depression is associated with heightened morbidity and mor-
tality in patients with cardiovascular disease [6–10]. It is alsoevier B.V. All rights reserved.
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Fig. 1. Interaction of psychological distress and risk factors/modulators in patients
with implantable cardioverter deﬁbrillators (ICDs). PTSD, posttraumatic stress
disorder.
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Fig. 2. Prevalence of depression at baseline and 2-year follow-up in 90 patients
with an implantable cardioverter deﬁbrillator. (From Suzuki et al. [19]).
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[11,12]. The prevalence of depression is reported to be 1 in 5 and
1 in 3 among outpatients with coronary artery disease and heart
failure, respectively [10]. In previous studies, depression has been
observed in 24–33% of patients receiving ICD therapy [3]. Bilge
et al. reported that depression scores obtained using the Hospital
Anxiety and Depression Scale were higher in patients who had an
ICD for an extended period (45 years) or in those who had
received recent shock therapy (within the past 6 months) [13].
Friedmann et al. also reported that Beck Depression Inventory
scores were higher in patients who had an ICD for 41 year
compared with those who had an ICD for o1 year [14]. The
Triggers of Ventricular Arrhythmia study suggested that moderate-
to-severe depression is a predictor of appropriate shocks in
patients with coronary artery disease and an ICD [15].
However, few studies have evaluated changes in depressive
state over time during ICD therapy. A small study of 25 ICD
patients found that 2 of 5 patients with depression continued in
this negative affective state for ≥1 year [16]. Another study showed
that depressive symptoms did not change in 132 ICD patients over
1 year, irrespective of whether they experienced shocks [17].
A study of 57 ICD patients with heart failure revealed that the
proportion of patients with depression decreased over a 2-year
period, although follow-up was not completed for 50% of the
enrolled patients [18]. Using the Zung Self-Rating Depression Scale
(index score ≥60), we reported that approximately 30% of 90
patients with an ICD had depression and that 72% of the patients
with depression showed persistent depression at the 2-year
follow-up (Fig. 2) [19]. Patients with depression at 2 years had
experienced more ICD shocks during this time than those without
depression [19]. Herrmann et al. showed that the percentage of
psychologically distressed ICD patients increased with an increase
in the number of shocks, especially in patients experiencing ≥10
shocks during the mean period of 1.4 years [20]. Bilge et al.
reported that depression scores according to the Hospital Anxiety
and Depression Scale were signiﬁcantly higher in patients who
had experienced shocks recently (within the last 6 months) [13].
These ﬁndings suggest that ICD shocks contribute to the persis-
tence of depression in these patients.
Biological mechanisms have also been associated with poor cardi-
ovascular outcomes in ICDpatientswith depression, such as alteration
of cardiac autonomic tone, activation of the sympathetic nervous
system, enhanced activity of the hypothalamic-pituitary-adrenal axis,
and elevated inﬂammatory and proinﬂammatory processes
[6,7,10,21]. Although depression is deﬁnitely associated with worse
outcomes in patients with cardiovascular disease, the pathophysiolo-
gical mechanisms of this association are not completely understood.
The following additional suspected risk factors and modulators
are suggested as markers for the need of psychosocial attention in
ICD patients: younger age (o50 years), inadequate knowledgeabout the cardiac condition or ICD, a signiﬁcant history of
psychological problems, poor social support, and high medical
severity or comorbidity [3]. Previous studies have reported that
the incidence of depression is generally higher in women than in
men [22,23]. Rahmawati et al. revealed that in a cohort study of
Japanese patients with an ICD, women had a higher incidence of
depression, according to the Beck Depression Inventory, and
worried more about their ICD than did men [24]. Therefore, sex
may also be a risk factor for depression in ICD patients.
Poor social support is also independently associated with poor
cardiovascular outcome [25]. Recently, a longitudinal study of 105
heart failure patients with and without an ICD designed to examine
changes in psychosocial status showed that depression increased
over time in patients with less initial social support, whereas it did
not increase in those with higher initial social support (Fig. 1) [26].
Kohn et al. found that cognitive behavior therapy (CBT) con-
ducted before implantation, before discharge, and at 7 routine
visits decreased depression at the 9-month follow-up in patients
with an ICD [27]. In another study, CBT also decreased anxiety and
ventricular arrhythmias requiring ICD therapy. However, the
effects were limited, and the depressive state of patients did not
change over the course of the intervention in this study [28]. The
effect of antidepressants such as selective serotonin reuptake
inhibitors on the depressive state of ICD patients has not yet been
established. Previous studies have suggested that the prevention
of ventricular arrhythmia, which requires shock therapy, may be
important for alleviating or preventing depression in patients
receiving long-term ICD therapy. Increase in social support may
also lead to reduction of depression and improvement in health-
related QOL in ICD patients with heart failure.3. Anxiety
Anxiety is common in patients with an ICD and has been reported
in 24–87% of patients after ICD implantation. The prevalence of
clinically diagnosed anxiety disorder ranges from 13% to 38% [3,29].
The number and frequency of ICD shocks experienced may increase
levels of anxiety because an ICD discharge causes fear and pain in
some patients. However, a review of the literature reveals that the
association between ICD shocks and anxiety is unclear. Some studies
have reported a signiﬁcant relationship between shocks and anxiety
[13,30,31], whereas others have found no relationships [32,33],
although there have been several limitations such as small numbers
of patients. In a study of 308 ICD patients, van den Broek et al. used
the State Trait Anxiety Inventory 2 months after implantation and
reported that patients who had experienced an ICD shock had a
higher level of anxiety than that of patients who had not been
subjected to a shock; these researchers suggested that ICD shocks are
related to increased levels of anxiety [31].
Moreover, the effect of ICD-related concerns or personality
traits on anxiety sensitivity in individuals may be important. A
study in 182 ICD patients by Pederson et al. showed that patients
who had experienced shocks scored higher on the ICD Patients
Concerns Questionnaire and that concerns about ICD (with the
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was an independent risk factor for anxiety (according to the
Hospital Anxiety and Depression Scale) [34]. A study by van den
Broek et al. in 308 ICD patients revealed that type D (according to
the 14-item Type D Personality Scale) patients scored higher on
the 16-item Anxiety Sensitivity Index than did non-type D
patients, and that type D personality and anxiety sensitivity, but
not shock, were independent predictors of anxiety [31]. Pedersen
et al. also showed that type D personality is associated with
increased anxiety in ICD patients [33,35]. Therefore, anxiety in
ICD patients does not appear to be simply related to the experi-
ence of shocks. Personality traits associated with anxiety sensitiv-
ity and ICD-related concerns, as well as the shocks experienced,
play important roles in the levels of anxiety in ICD patients.
Time-dependent changes in the level of anxiety and proportion
of patients with anxiety after ICD implantation are unclear. Among
patients treated with ICD for the secondary prevention of sudden
cardiac death, Kamphuis et al. suggested that the proportion of
patients with anxiety did not change from implantation to 12
months after discharge [36]. However, the level of anxiety may
decrease with time after implantation, especially in ICD patients
who do not experience shock [31].
Some studies have evaluated the role of emotional stress in the
occurrence of ventricular arrhythmias in ICD patients [15,37–39].
Lampert et al. reported that anxiety was not signiﬁcantly associated
with ventricular arrhythmia requiring shock therapy but that anger
was an independent predictor [38]. A study by van den Broek et al.
showed that the combination of anxiety and type D personality, but
not anxiety alone, predicted the occurrence of ventricular arrhythmia
requiring ICD therapies in the ﬁrst year after implantation [39]. The
biological mechanisms underlying this ﬁnding are not understood;
however, it appears that intensive emotional stress may increase the
sympathetic tone, leading to the occurrence of arrhythmia.4. Posttraumatic stress disorder
Life-threatening cardiovascular disease is recognized as a cause of
acute distress and posttraumatic stress disorder (PTSD). PTSD occurs
in people who have been exposed to an extreme stressor or a
traumatic life-threatening event and experience fear, helplessness, or
horror. Three distinct types of symptoms, namely, re-experiencing of
the event, avoiding reminders of the event, and hyperarousal, must
be present for ≥1 month for a diagnosis of PTSD [40].
The prevalence of PTSD in the general population is estimated to
be 7.8% [41], whereas it is 30% and 15% in patients who have survived
cardiac arrest [42,43] and those who have myocardial infarction,
respectively [44,45]. Recently, trauma-induced reactions such as
PTSD have received attention in ICD patients because shock therapy
may have a traumatic impact on patients and may act as a
continuous reminder of the presence of a potentially fatal disease
[46–49]. The prevalence of PTSD in ICD patients has been reported to
be approximately 20%, although neither the deﬁnition of PTSD nor
the clinical characteristics of patients were uniform across the studies
[50–54]. A recent study by Rahmawati et al. reported the prevalence
(23.5%) of a PTSD score of ≥20 using the Impact of Event Scale-
Revised (IES-R) in Japanese patients with an ICD; this result is
comparable to previously reported results [24]. Kapa et al. found
that 21% of 223 ICD patients met the criteria for PTSD with an IES-R
score ≥24 at initial assessment (within 2 months after implantation),
which decreased signiﬁcantly to 12% after 6 months. The prevalence
remained relatively stable at 13% at 1 year after implantation [51].
However, von Känel documented an increase in IES-R score from
baseline to follow-up and found that nearly one-ﬁfth of patients had
newly developed PTSD 2–5.5 years after implantation in a cohort of
107 consecutive patients with an ICD [52].The mechanism underlying the development of PTSD and the
effect of PTSD on clinical outcomes in ICD patients are not well
documented. It is not clear whether cardiac status such as life-
threatening arrhythmia provokes PTSD or whether ICD shocks can
trigger and maintain PTSD. Habibović et al. suggested that ICD shocks
themselves were not signiﬁcantly associated with PTSD. For the 30
(7.6%) of 395 ICD patients in their study who met PTSD criteria, type
D personality and baseline anxiety were signiﬁcant predictors of
posttraumatic stress at 18 months after implantation, independent of
shocks and other clinical or demographic covariates [54]. However,
Kapa et al. revealed that although no signiﬁcant differences were
observed in IES-R among the patients who experienced ICD shocks,
5 patients who experienced electrical storms had signiﬁcantly higher
baseline PTSD scores [51]. von Känel et al. also showed that
experiencing ≥5 ICD shocks was a predictor of PTSD [52]. Moreover,
Ladwig et al. reported that the relative mortality risk was 3.45
(adjusted for age, sex, diabetes, left ventricular ejection fraction,
beta-blocker use, depression, and anxiety) in ICD patients with PTSD
(high IES-R score) compared with those without PTSD [50]. To date,
personality traits such as type D, comorbidities (e.g., underlying
cardiac disease, life-threatening arrhythmia, and anxiety), and fre-
quent ICD shocks or electrical storms have been found to be key
contributors to PTSD. In addition, persistent PTSD may be a predictor
of prognosis in ICD patients.
The primary tool in the pharmacological management of PTSD
is the use of selective serotonin reuptake inhibitors [55,56], but
positive response rates are generally limited. In addition, non-
pharmacological treatment such as CBT has been shown to be
effective for PTSD [57].5. Psychological distress in partners of ICD patients
Recently, attention has been focused on psychological distress
in the partners of ICD patients. Studies have reported that the
distress level in partners of ICD patients was as high as that in the
patients themselves [58]. In most partners, this distress level
seems to decrease in the ﬁrst year after implantation of an ICD
[58]. The predictive factors of psychological distress in partners of
ICD patients considered in the literature are age, secondary
indication for ICD implantation, and personality traits such as
type D, although the causal relationships are unclear [33,59].
Moreover, the inﬂuence of ICD shocks on the distress in partners
of ICD patients is also complex and ranges from some to no impact
on distress levels. However, it is not possible to draw conclusions
on these issues because of the small number of studies examining
psychological distress in partners of patients with an ICD.6. Conclusions
Psychological distress is not uncommon among patients receiv-
ing long-term ICD therapy. The prevalence of distress in ICD
patients is increasing because the guidelines for implantation are
expanding to include the primary prevention of sudden cardiac
death in high-risk patients. However, ICD-induced psychological
distress may impair lifestyle or QOL in patients. Therefore, in ICD
patients, the management of psychological distress is as necessary
as the prevention of sudden cardiac death. Cardiologists and
clinical electrophysiologists should screen for psychological dis-
tress in ICD patients and consult psychiatrists when appropriate.Conﬂicts of interests
None declared.
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